Insights

Regenerative focus Frequency Therapeutics operates in regenerative medicine with a platform aimed at activating the body’s innate regenerative potential, presenting opportunities for partnerships or collaborations around cell activation therapies and remyelination strategies.

Preclinical lead The company’s lead program targets oligodendrocyte precursor cells to drive remyelination, suggesting potential sales conversations around preclinical research services, contract development, or collaborative funding with academic or pharma partners pursuing MS functional recovery.

Recent merger Frequency merged with Korro Bio in 2023, indicating a broadened capability base and potential for cross-sell of platform capabilities, shared IP opportunities, and strategic alignments with broader neuroscience and regenerative pipelines.

Funding & scale With a funding pool of approximately $180M and revenue in the low single-digit millions, there is room for BD discussions around strategic collaborations, milestone-based partnerships, or licensing deals to accelerate pipeline progression.

Technology stack Utilizes cloud and analytics tools (AWS, Google Cloud, NetSuite, New Relic) and data-driven operations, suggesting opportunities to offer scalable bioinformatics, cloud-enabled data management, or collaboration platforms tailored to biotech R&D workflows.

Similar companies to Frequency Therapeutics

Frequency Therapeutics Tech Stack

Frequency Therapeutics uses 8 technology products and services including SAS, Amazon Web Services, Drupal, and more. Explore Frequency Therapeutics's tech stack below.

Media & News

Frequency Therapeutics's Email Address Formats

Frequency Therapeutics uses at least 4 email formats:
Frequency Therapeutics Email FormatsExamplePercentage
FLast@frequencytx.comJDoe@frequencytx.com
83%
Last@frequencytx.comDoe@frequencytx.com
14%
First.Last@frequencytx.comJohn.Doe@frequencytx.com
2%
FL@frequencytx.comJD@frequencytx.com
1%

Frequently Asked Questions

What is Frequency Therapeutics's phone number?

Minus sign iconPlus sign icon
You can contact Frequency Therapeutics's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Frequency Therapeutics's stock symbol?

Minus sign iconPlus sign icon
Frequency Therapeutics is a publicly traded company; the company's stock symbol is KRRO.

What is Frequency Therapeutics's official website and social media links?

Minus sign iconPlus sign icon
Frequency Therapeutics's official website is frequencytx.com and has social profiles on LinkedIn.

How much revenue does Frequency Therapeutics generate?

Minus sign iconPlus sign icon
As of July 2026, Frequency Therapeutics's annual revenue is estimated to be $1M - $10M.

What is Frequency Therapeutics's SIC code and NAICS code?

Minus sign iconPlus sign icon
Frequency Therapeutics's SIC code is 8731 - Commercial Physical and Biological Research and NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Frequency Therapeutics have currently?

Minus sign iconPlus sign icon
As of July 2026, Frequency Therapeutics has approximately 51 employees across 4 continents, including North America, Europe and Asia. Key team members include Chief Development Officer: R. M., Co-Founder: C. L. and Senior Director, Regulatory Toxicologist: M. R. Explore Frequency Therapeutics's employee directory with LeadIQ.

What industry does Frequency Therapeutics belong to?

Minus sign iconPlus sign icon
Frequency Therapeutics operates in the Biotechnology Research industry.

What technology does Frequency Therapeutics use?

Minus sign iconPlus sign icon
Frequency Therapeutics's tech stack includes SAS, Amazon Web Services, Drupal, NetSuite, Microsoft 365, Google Cloud, New Relic and Adobe Creative Suite.

What is Frequency Therapeutics's email format?

Minus sign iconPlus sign icon
Frequency Therapeutics's email format typically follows the pattern of FLast@frequencytx.com. Find more Frequency Therapeutics email formats with LeadIQ.

How much funding has Frequency Therapeutics raised to date?

Minus sign iconPlus sign icon
As of July 2026, Frequency Therapeutics has raised $180M in funding. The last funding round occurred on Aug 15, 2022.

When was Frequency Therapeutics founded?

Minus sign iconPlus sign icon
Frequency Therapeutics was founded in 2015.
Frequency Therapeutics logo

Frequency Therapeutics

Biotechnology ResearchMassachusetts, United States51-200 Employees

Frequency Therapeutics is a biotechnology research company focused on regenerative medicine as a distinct area of practice. It aims to unlock the body's innate regenerative potential through a progenitor cell activation approach. Its lead preclinical program is designed to stimulate oligodendrocyte precursor cells to promote remyelination and potential functional recovery for people living with multiple sclerosis.

The company is based in Lexington, Massachusetts, operating within the biotechnology research sector and described as a smaller to mid-sized enterprise. A notable development in July 2023 was the announced merger with Korro Bio, reflecting strategic consolidation in the field.

Section iconCompany Overview

Phone number
SIC Code
8731 - Commercial Physical and Biological Research
Stock Symbol
KRRO
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2015
Employees
51-200

Section iconFunding & Financials

  • $180M

    Frequency Therapeutics has raised a total of $180M of funding over 8 rounds. Their latest funding round was raised on Aug 15, 2022 as a Post IPO Equity.

  • $1M - $10M

    Frequency Therapeutics's revenue is estimated to be in the range of $1M - $10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.